Description
BSE announces listing of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 1, 2025.
Summary
BSE announces the listing of 1000 bonus equity shares of Ipca Laboratories Ltd (Scrip Code: 524494) that were kept in abeyance. These shares will be listed and permitted for trading effective Monday, September 1, 2025.
Key Points
- 1000 bonus equity shares of Rs. 1/- each kept in abeyance
- ISIN: INE571A01038
- Distinctive numbers: 1171453 to 1172452
- Trading permitted from September 1, 2025
- Notice issued by Deputy Vice President Ashok Kumar Singh
Regulatory Changes
No regulatory changes - this is a routine listing of previously issued bonus shares that were kept in abeyance.
Compliance Requirements
Trading members are informed of the new securities available for trading. No specific compliance actions required beyond normal trading procedures.
Important Dates
- September 1, 2025: Effective date for listing and trading of bonus shares
Impact Assessment
Minimal market impact as this involves a small number of bonus shares (1000 shares) that were previously issued but kept in abeyance. The listing enables these shares to be traded normally.
Impact Justification
Routine listing of bonus shares kept in abeyance with minimal market impact